Medications

FDA approves Xdemvy for Demodex blepharitis

The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites.

Medical research

New antibiotics on the way, but not quickly enough

A report by University of Queensland researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics.

page 8 from 40